DE69619250D1 - Verbesserte arzneimittel mit einem ionenaustauschharz - Google Patents
Verbesserte arzneimittel mit einem ionenaustauschharzInfo
- Publication number
- DE69619250D1 DE69619250D1 DE69619250T DE69619250T DE69619250D1 DE 69619250 D1 DE69619250 D1 DE 69619250D1 DE 69619250 T DE69619250 T DE 69619250T DE 69619250 T DE69619250 T DE 69619250T DE 69619250 D1 DE69619250 D1 DE 69619250D1
- Authority
- DE
- Germany
- Prior art keywords
- ion exchange
- exchange resin
- pct
- date
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9517883.6A GB9517883D0 (en) | 1995-09-01 | 1995-09-01 | Improved pharmaceutical ion exchange resin composition |
PCT/GB1996/002156 WO1997009036A2 (en) | 1995-09-01 | 1996-09-02 | Improved pharmaceutical ion exchange resin composition |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69619250D1 true DE69619250D1 (de) | 2002-03-21 |
DE69619250T2 DE69619250T2 (de) | 2002-08-14 |
Family
ID=10780065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69619250T Expired - Lifetime DE69619250T2 (de) | 1995-09-01 | 1996-09-02 | Verbesserte arzneimittel mit einem ionenaustauschharz |
Country Status (9)
Country | Link |
---|---|
US (1) | US6077532A (de) |
EP (1) | EP0847273B1 (de) |
AT (1) | ATE213152T1 (de) |
AU (1) | AU6834796A (de) |
DE (1) | DE69619250T2 (de) |
ES (1) | ES2170258T3 (de) |
GB (1) | GB9517883D0 (de) |
PT (1) | PT847273E (de) |
WO (1) | WO1997009036A2 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2288876A1 (en) * | 1997-05-06 | 1998-11-12 | Xiao Yu Wu | Drug delivery system |
WO1999032119A1 (en) * | 1997-12-22 | 1999-07-01 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
UA53774C2 (uk) * | 1997-12-22 | 2003-02-17 | Еро-Селтік, С.А. | Спосіб запобігання зловживанню лікарськими формами, що містять опіоїди |
US6221308B1 (en) * | 1999-04-20 | 2001-04-24 | Corning Incorporated | Method of making fired bodies |
HU229705B1 (en) * | 2000-02-08 | 2014-05-28 | Euro Celtique Sa | Tamper-resistant oral opioid agonist formulations |
NZ520975A (en) * | 2000-02-24 | 2004-03-26 | Upjohn Co | New drug combinations containing a norepinephrine reuptake inhibitor and an antimuscarinic agent for treating nervous system disorders |
ATE493130T1 (de) | 2001-05-11 | 2011-01-15 | Endo Pharmaceuticals Inc | Opioid enthaltende arzneiform gegen missbrauch |
DE60230632D1 (de) * | 2001-07-18 | 2009-02-12 | Euro Celtique Sa | Pharmazeutische kombinationen von oxycodon und naloxon |
WO2003013433A2 (en) | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Sequestered antagonist formulations |
ATE431738T1 (de) | 2001-08-06 | 2009-06-15 | Euro Celtique Sa | Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
US20040067216A1 (en) * | 2002-02-22 | 2004-04-08 | Karki Shyam B. | Hiv protease inhibitors supported on cation exchange resins for oral administration |
EP2243471A1 (de) | 2002-04-05 | 2010-10-27 | Euro-Celtique S.A. | Matrix für die modifizierte Freigabe von aktiven Substanzen |
DK1551372T3 (en) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES |
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
TWI347201B (en) | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
AU2004270188B8 (en) * | 2003-09-03 | 2010-04-29 | Mallinckrodt Inc. | Granular sustained release preparation and production thereof |
US20050181050A1 (en) * | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
US20070232695A1 (en) * | 2004-01-28 | 2007-10-04 | Collegium Pharmaceutical, Inc. | Gelled Periodontal Anesthetic Preparation |
EP1604666A1 (de) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit |
WO2006081518A2 (en) * | 2005-01-28 | 2006-08-03 | Collegium Pharmaceutical, Inc. | Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents |
EP1702558A1 (de) * | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Verfahren und Vorrichtung zur Darmtätigkeitserfassung |
US8343546B2 (en) * | 2005-09-13 | 2013-01-01 | Coating Place, Inc. | Ion exchange resin treated to control swelling |
EP1834634A3 (de) * | 2006-03-08 | 2007-10-03 | Rentschler Pharma GmbH | Aus mehrfacher Einzeleinheiten bestehender pharmazeutische Zusammensetzung |
CN101677963B (zh) | 2006-06-19 | 2012-05-30 | 奥尔制药公司 | 药物组合物 |
EP2120945A1 (de) * | 2007-02-28 | 2009-11-25 | Collegium Pharmaceutical, Inc. | Antihistamin-kombination |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
DK2405915T3 (en) | 2009-03-10 | 2019-02-11 | Euro Celtique Sa | PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE INCLUDING OXYCODON AND NALOXON |
KR20180037074A (ko) | 2013-07-23 | 2018-04-10 | 유로-셀티큐 에스.에이. | 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3627583A (en) * | 1969-04-29 | 1971-12-14 | Sucrest Corp | Direct compression vehicles |
EP0200252B1 (de) * | 1985-05-02 | 1999-03-10 | Yamanouchi Europe B.V. | Trimethoprim und ein Sulfonamid enthaltende Tabletten |
EP0328877A1 (de) * | 1988-02-18 | 1989-08-23 | Oerlikon-Contraves AG | Geschoss mit Splittermantel |
FI81004C (fi) * | 1988-02-25 | 1990-09-10 | Suomen Sokeri Oy | Binde- och utspaedningsmedel pao basis av xylitol och foerfarande foer dess framstaellning. |
CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
HU206975B (en) * | 1991-03-14 | 1993-03-01 | Reanal Finomvegyszergyar | Process for producing granulation and veterinary composition comprising water-soluble flumequine complex |
-
1995
- 1995-09-01 GB GBGB9517883.6A patent/GB9517883D0/en active Pending
-
1996
- 1996-09-02 DE DE69619250T patent/DE69619250T2/de not_active Expired - Lifetime
- 1996-09-02 ES ES96928628T patent/ES2170258T3/es not_active Expired - Lifetime
- 1996-09-02 EP EP96928628A patent/EP0847273B1/de not_active Expired - Lifetime
- 1996-09-02 AU AU68347/96A patent/AU6834796A/en not_active Abandoned
- 1996-09-02 AT AT96928628T patent/ATE213152T1/de active
- 1996-09-02 WO PCT/GB1996/002156 patent/WO1997009036A2/en active IP Right Grant
- 1996-09-02 US US09/029,151 patent/US6077532A/en not_active Expired - Lifetime
- 1996-09-02 PT PT96928628T patent/PT847273E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
GB9517883D0 (en) | 1995-11-01 |
ES2170258T3 (es) | 2002-08-01 |
EP0847273B1 (de) | 2002-02-13 |
US6077532A (en) | 2000-06-20 |
WO1997009036A2 (en) | 1997-03-13 |
ATE213152T1 (de) | 2002-02-15 |
AU6834796A (en) | 1997-03-27 |
WO1997009036A3 (en) | 1997-04-24 |
EP0847273A2 (de) | 1998-06-17 |
PT847273E (pt) | 2002-06-28 |
DE69619250T2 (de) | 2002-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69619250T2 (de) | Verbesserte arzneimittel mit einem ionenaustauschharz | |
AU5106996A (en) | Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby | |
NO971986D0 (no) | Fremgangsmåte for fremstilling av små partikler | |
AU4453089A (en) | Pharmaceutical ion exchange resin composition | |
BR9407239A (pt) | Azadioxacicloalquenos substituídos | |
AU4115396A (en) | 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these | |
AU6870396A (en) | New pyrimidone derivatives with antifungal activity | |
ATE259815T1 (de) | Neue antagonistische verbindungen | |
NO973646D0 (no) | Orale doseringsformer inneholdende et <beta>-laktam antibiotikum | |
CA2104917A1 (en) | Use of Certain Anionic Surfactants to Enhance Antimicrobial Effectiveness of Ophthalmic Compositions | |
AU6415796A (en) | Pharmaceutical composition containing lamotrigine | |
PT97541A (pt) | Processo para a preparacao de indoles substituidos | |
HU9602041D0 (en) | Oral dosage form containing colestipol as a carrier and acidic substances and a process for producing the same | |
PT871632E (pt) | Producao de um sal cristalino de amoxicilina | |
SE9401596D0 (sv) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |